FTIH Study With GSK958108

NCT00664365 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Premature Ejaculation

Interventions

DRUG: GSK958108
DRUG: Placebo

Sponsor

GlaxoSmithKline